Combined HRT Increases Risk of Lobular Breast Cancer Fourfold After Just Three Years of Use
Fred Hutchinson Cancer CenterPostmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.